ABT – Abbott Laboratories

Abbott Laboratories

ABT

$100.34

Name : Abbott Laboratories

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $174,773,518,336.00

EPSttm : 3.1

Abbott Laboratories

$100.34

2.91%

$2.84

ABT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.16

Margin Of Safety %

Put/Call OI Ratio

0.6

EPS Next Q Diff

0.33

EPS Last/This Y

0.37

EPS This/Next Y

0.55

Price

97.5

Target Price

121.08

Analyst Recom

1.53

Performance Q

1.96

Upside

-30.3%

Beta

0.55

Ticker: ABT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-08	ABT	105.57	0.57	0.88	236445
2026-09-09	ABT	105.23	0.57	0.92	238094
2026-09-10	ABT	103.38	0.58	2.27	239967
2026-09-11	ABT	101.97	0.59	0.95	242385
2026-09-14	ABT	103.09	0.61	0.33	241399
2026-09-15	ABT	102.02	0.61	0.61	242676
2026-09-16	ABT	102.36	0.60	0.55	243535
2026-09-17	ABT	102.23	0.58	1.51	245604
2026-09-18	ABT	102.54	0.58	0.50	248014
2026-09-21	ABT	102.99	0.65	0.37	190585
2026-09-22	ABT	103.72	0.64	0.30	195109
2026-09-23	ABT	103.53	0.63	0.32	198394
2026-09-24	ABT	101.07	0.62	0.23	206759
2026-09-25	ABT	101.3	0.61	1.18	210322
2026-09-28	ABT	100.99	0.62	0.16	210216
2026-09-29	ABT	100.96	0.60	1.07	215657
2026-09-30	ABT	98.82	0.61	0.38	219427
2026-10-01	ABT	96.7	0.61	0.95	220875
2026-10-02	ABT	97.49	0.60	0.40	222180
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-08	ABT	105.57	9.2	2693.5	5.52
2026-09-09	ABT	105.17	9.2	2910.6	5.52
2026-09-10	ABT	103.38	9.2	2771.2	5.52
2026-09-11	ABT	101.97	9.2	2811.9	5.52
2026-09-14	ABT	103.09	9.2	3051.8	5.52
2026-09-15	ABT	102.05	9.2	2844.7	5.52
2026-09-16	ABT	102.05	9.2	2844.7	5.52
2026-09-17	ABT	102.24	9.2	2931.6	5.52
2026-09-18	ABT	102.54	9.2	2973.0	5.52
2026-09-21	ABT	102.97	9.2	2977.6	5.52
2026-09-22	ABT	103.74	9.2	3014.8	5.52
2026-09-23	ABT	103.53	9.2	2927.9	5.52
2026-09-24	ABT	101.07	9.2	2715.0	5.52
2026-09-25	ABT	101.29	9.2	2964.1	5.52
2026-09-28	ABT	100.98	9.2	2913.3	5.52
2026-09-29	ABT	100.96	9.2	2941.1	5.52
2026-09-30	ABT	98.82	9.2	2739.1	5.52
2026-10-01	ABT	96.70	9.2	2734.8	5.52
2026-10-02	ABT	97.50	9.2	2812.5	5.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-08	ABT	-3.17	-1.37	1.19
2026-09-09	ABT	-3.17	-1.37	1.19
2026-09-10	ABT	-3.17	-1.37	1.19
2026-09-11	ABT	-3.17	-1.37	1.29
2026-09-14	ABT	-3.17	-1.35	1.29
2026-09-15	ABT	-3.17	-1.35	1.29
2026-09-16	ABT	-3.17	-1.35	1.29
2026-09-17	ABT	-3.17	-1.35	1.29
2026-09-18	ABT	-3.17	-1.35	1.29
2026-09-21	ABT	-3.17	-1.35	1.29
2026-09-23	ABT	-3.17	-1.35	1.29
2026-09-24	ABT	-3.17	-1.35	1.29
2026-09-25	ABT	-3.17	-1.35	1.16
2026-09-28	ABT	-3.17	-1.35	1.16
2026-09-29	ABT	-3.17	-1.35	1.16
2026-09-30	ABT	-3.17	-1.35	1.16
2026-10-01	ABT	-3.17	-1.35	1.16
2026-10-02	ABT	-3.21	-1.35	1.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.31

Avg. EPS Est. Current Quarter

1.42

Avg. EPS Est. Next Quarter

1.64

Insider Transactions

-3.21

Institutional Transactions

-1.35

Beta

0.55

Average Sales Estimate Current Quarter

12991

Average Sales Estimate Next Quarter

13541

Fair Value

121.63

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.6

Max Drawdown 5-Year %

-39.6

Target Price

121.08

P/E

31.51

Forward P/E

16.08

PEG

1.73

P/S

3.62

P/B

3.3

P/Free Cash Flow

21.56

EPS

3.09

Average EPS Est. Cur. Y

5.52

EPS Next Y. (Est.)

6.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.6

Relative Volume

0.89

Return on Equity vs Sector %

-15.6

Return on Equity vs Industry %

-0.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

2812.5

◆ ABT Healthcare

$97.50

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

19/25

Volume

7/15

Valuation

20/20

TP/AR

1/10

Options

5/10

RSI

29.7

Range 1M

14.4%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

10/30

Estimates

6/20

Inst/Vol

1/15

Options

7/10

EPS Yr

7.1%

EPS NY

10%

52W%

29.1%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +30.8% upside

Quality

11/30

Valuation

16/30

Growth

7/25

Stability

5/10

LT Trend

4/5

Upside

+30.8%

Quality

MoS

25%

ABT — P/E HistoricalMedical Devices

Abbott Laboratories

Sector: Healthcare

Industry: Medical Devices

Employees: 122000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

ABT

Latest News

—

Caricamento notizie per ABT…

stock quote shares ABT – Abbott Laboratories Stock Price stock today

news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025

marketwatch ABT – Abbott Laboratories yahoo finance google finance

stock history ABT – Abbott Laboratories invest stock market

stock prices ABT premarket after hours

ticker ABT fair value insiders trading

ABT – Abbott Laboratories

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y